Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 18;16(1):425.
doi: 10.1186/s13256-022-03651-w.

Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series

Affiliations
Case Reports

Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series

Ane Rogne et al. J Med Case Rep. .

Abstract

Background: Attention deficit/hyperactivity disorder (ADHD) entails inattention, impulsivity, and restlessness at a disabling level. The pharmacological treatment of ADHD rests on the use of centrally acting stimulants, such as methylphenidate and D-amphetamine. In some patients, these drugs cause side effects that preclude their use.

Case presentation: We present three adult male, Caucasian, ADHD patients (24, 37, and 43 years old) whose ADHD symptoms improved during treatment with testosterone. The first patient experienced loss of libido during treatment with methylphenidate; for this, he was offered a trial of testosterone. Unexpectedly, his ADHD symptoms improved with testosterone treatment, and this effect continued with testosterone as monotherapy. The two other patients, who also had side effects from centrally acting stimulants, received testosterone monotherapy with similar results. The effect has now continued for 4.5-5 years at the same doses: 10-60 mg testosterone/day, administered as a skin gel. Prior to testosterone treatment, the patients had serum levels of testosterone in the low-normal range: 12-16 nmol/L (age-specific reference range: 10.4-32.6 nmol/L). The testosterone/sex hormone-binding globulin ratio was low in two patients (0.32 and 0.34; age-specific reference range: 0.38-1.1), suggesting low free serum levels of testosterone. Serum testosterone levels and testosterone/sex hormone-binding globulin ratios increased with testosterone treatment in all patients, but remained within reference values.

Conclusion: These cases suggest that a moderately reduced serum level of free testosterone may contribute to the ADHD symptoms of some adult male ADHD patients, and that testosterone treatment may be of value for these patients.

Keywords: ADHD; Attention deficit/hyperactivity disorder; Case report; Impulsivity; Inattention; Sex hormone-binding globulin; Side effects; Testosterone treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the work was conducted in the absence of any commercial or financial relationships that could be understood as a potential conflict of interest.

Similar articles

Cited by

References

    1. American Psychiatry Association . Diagnostic and Statistical Manual of Mental Disorders (Fifth edition) Washington: American Psychiatry Publishing; 2013.
    1. Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050–1056. doi: 10.1056/NEJMra1917069. - DOI - PubMed
    1. Ching C, Eslick GD, Poulton AS. Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit/hyperactivity disorder: a meta-analysis. JAMA Pediatr. 2019;173(7):630–639. doi: 10.1001/jamapediatrics.2019.0905. - DOI - PMC - PubMed
    1. Dolder PC, Müller F, Schmid Y, Borgwardt SJ, Liechti ME. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology. 2018;235(2):467–479. doi: 10.1007/s00213-017-4650-5. - DOI - PMC - PubMed
    1. Chierrito de Oliveira D, Guerrero de Sousa P, Borges Dos Reis C, Tonin FS, Maria Steimbach L, Virtuoso S, et al. Safety of treatments for ADHD in adults: pairwise and network meta-analyses. J Atten Disord. 2019;23(2):111–120. doi: 10.1177/1087054717696773. - DOI - PubMed

Publication types

MeSH terms